Skip Navigation


Journal of Biochemistry Advance Access originally published online on February 5, 2007
Journal of Biochemistry 2007 141(2):279-286; doi:10.1093/jb/mvm038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
141/2/279    most recent
mvm038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yokoyama, N.
Right arrow Articles by Handa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoyama, N.
Right arrow Articles by Handa, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Japanese Biochemical Society.

Mutational Analysis of the Carboxyl-terminal Region of the SV40 Major Capsid Protein VP1

Naoki Yokoyama1, Masa-aki Kawano1, Hiroko Tsukamoto1, Teruya Enomoto1, Takamasa Inoue1, Ryou-u Takahashi1, Akira Nakanishi2, Takeshi Imai2, Tadashi Wada1,3 and Hiroshi Handa1,*

1Graduate School of Bioscience and Biotechnology, and 3Integrated Research Institute, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan; and 2National Institute of Longevity Sciences, 36-3 Gengo, Morioka-machi, Obu 474-8511, Japan

*To whom correspondence should be addressed. Tel: +81-45-924-5872, Fax: +81-45-924-5834, E-mail: hhanda{at}bio.titech.ac.jp

Received November 21, 2006; Accepted December 10, 2006


   Abstract

Virus-like particles (VLPs), a promising next-generation drug delivery vehicle, can be formed in vitro using a recombinant viral capsid protein VP1 from SV40. Seventy-two VP1 pentamers interconnect to form the T = 7d lattice of SV40 capsids, through three types of C-terminal interactions, {alpha}-{alpha}'-{alpha}'', ß-ß' and {gamma}-{gamma}. These appear to require VP1 conformational switch, which involve in particular the region from amino acids 301–312 (herein Region I). Here we show that progressive deletions from the C-terminus of VP1, up to 34 amino acids, cause size and shape variations in the resulting VLPs, including tubular formation, whereas deletions beyond 34 amino acids simply blocked VP1 self-assembly. Mutants carrying in Region I point mutations predicted to disrupt {alpha}-{alpha}'-{alpha}''-type and/or ß-ß'-type interactions formed small VLPs resembling T = 1 symmetry. Chimeric VP1, in which Region I of SV40 VP1 was substituted with the homologous region from VP1 of other polyomaviruses, assembled only into small VLPs. Together, our results show the importance of the integrity of VP1 C-terminal region and the specific amino acid sequences within Region I in the assembly of normal VLPs. By understanding how to alter VLP sizes and shapes contributes to the development of drug delivery systems using VLPs.

Key Words: baculovirus, carboxyl-terminal of VP1, self-assembly, simian virus 40, virus-like particles


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GENES CELLSHome page
H. Tsukamoto, M.-a. Kawano, T. Inoue, T. Enomoto, R.-u Takahashi, N. Yokoyama, N. Yamamoto, T. Imai, K. Kataoka, Y. Yamaguchi, et al.
Evidence that SV40 VP1-DNA interactions contribute to the assembly of 40-nm spherical viral particles.
Genes Cells, November 1, 2007; 12(11): 1267 - 1279.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.